Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company has healthcare services/product distribution centres in India and the African continent. Considering the business tie-ups between India and Africa on healthcare, this company is poised for bright prospects ahead. FY23 financial performance hints at the opportunities lying ahead. Investors may park funds for short to long-term rewards. Read detail review...
Unihealth Consultancy Limited peer comparison with similar listed entities. (Consolidated) (As on March 31, 2023)
Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | |
---|---|---|---|---|---|
EPS Basic | EPS Diluted | ||||
Unihealth Consultancy Limited | 6.94 | 6.94 | 27.91 | ||
KMC Speciality Hospitals (India) Ltd | 1.64 | 1.64 | 6.96 | 44.88 | 23.51 |
Notes:
Unihealth Consultancy IPO Reviews, analysis and views by popular members. Read Unihealth Consultancy Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note:
Useful Articles